🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2b, randomized, open label study to assess the safety and e...
Status
Recruiting
Location
Compassionate Cancer Care Medical Group
Start Date
2021-06-18
Trial ID
NCT04920617
Treatments Being Tested
The main objective of this multicenter study will therefore be to evaluate ...
Status
Completed
Location
Institut de Cancerologie de L'Ouest - Site Paul Papin
Start Date
2015-01
Trial ID
NCT02339532
Treatments Being Tested
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
This phase I trial tests the safety, side effects, best dose of MUC1-activa...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-09-20
Trial ID
NCT06483048
Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2004-03-14
Trial ID
NCT00211185
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
This is a study of a regimen of melphalan and autologous stem cells for pat...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-04-20
Trial ID
NCT00177047
Treatments Being Tested
Post-transplantation lymphoproliferative disorder (PTLD) develops in one to...
Status
Terminated
Location
Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Qld 4102
Start Date
2002-12
Trial ID
NCT01458548
SUMMARY: Metronomic Therapy in Patients with Metastatic Melanoma: A Phase I...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2010-06
Trial ID
NCT01542255
Treatments Being Tested
Interstitial lung disease (ILD) is characterised by inflammation and scarri...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2014-11
Trial ID
NCT01862926
Treatments Being Tested